# Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

> **NCT00613626** · PHASE2 · COMPLETED · sponsor: **Hoosier Cancer Research Network** · enrollment: 74 (actual)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Etoposide
- **DRUG:** Placebo
- **DRUG:** ZD6474

## Key facts

- **NCT ID:** NCT00613626
- **Lead sponsor:** Hoosier Cancer Research Network
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2020-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00613626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00613626, "Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00613626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*